[1]Patent:WO2009/147189,2009,A1
1439373-55-3
300582-83-6
878010-24-3
919286-65-0
847805-30-5
841274-05-3
7681-78-9 | mebezonium iodide | AA00G9GJ | MFCD00274164
811812-57-4 | 2-(Piperidin-4-ylmethyl)pyridine | AA00G9MR | MFCD05189963
846038-33-3 | 3-Fluoroquinolin-8-amine | AA00G9ZS | MFCD18802884
79655-96-2 | Ethyl 3-(2-aminophenyl)acrylate | AA00GAF3 | MFCD12407284
835879-06-6 | 2-Amino-5-(4-methylpiperazin-1-yl)benzoic acid | AA00GBP1 | MFCD12869794
75250-52-1 | Methyl 4-hydroxypiperidine-1-carboxyl | AA00GFXS | MFCD12181166
8064-90-2 | Co-trimoxazole | AA00GJ2A | MFCD00242808
758684-88-7 | Methyl 3-aminobicyclo[1.1.1]pentane-1-carboxylate | AA00GM8G | MFCD23164156
795-18-6 | 3-(Benzyl-ethoxycarbonylmethyl-amino)-propionic acid ethyl ester | AA00GPA3 | MFCD09833363
927-20-8 | Dl-alpha-glycerol phosphate magnesium salt hydrate | AA00GR9L | MFCD00050731